PFE News and Press, Pfizer Inc. From 07/01/24

Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the Audit Committee and Compensation Committee of Pfizer’s Board. Mr. Taraporevala served as Presid...

2024-06-30 06:24:00 ET If you're an investor who doesn't already have access to billions in capital, you could probably learn a few things from the folks who do. Luckily, keeping tabs on the world's most successful investors isn't very hard to do. Every three months, people managing a p...

2024-06-30 05:58:23 ET Summary Elanco Animal Health shares have dropped over 20% due to a delay in the innovative product pipeline, but potential for a recovery remains. The company's divestment of the aqua business at a high sales multiple reduced leverage ratios, improving the o...

2024-06-29 15:44:55 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk Breaks Out To An All-Time High On China Approval Of Wegovy Eli Lilly: Throwing Its Weight Around - But, For How Long? (Technical Analysis) Eli Lilly: The Party Is Probably Nearing The End ...

2024-06-29 09:00:00 ET Summary Income investors should focus on decent income and total returns exceeding inflation by at least 4%, not necessarily matching S&P500 returns. Investing in funds like ETFs and CEFs can offer diversification, ease of trading, and potential for acti...

2024-06-28 07:55:34 ET This week's dividend activity included increased payouts from Kroger ( NYSE: KR ) and Levi Strauss ( LEVI ) as well as declarations from companies like AT&T ( NYSE: T ) and Pfizer ( NYSE: PFE ).... Read the full article on Seeking...

2024-06-27 14:14:36 ET Summary Top-line data from Part B of phase 3 RINGSIDE study, using AL102 for the treatment of patients with desmoid tumors, expected 2nd half of 2025. The global desmoid tumor market is projected to grow to $5.49 billion by 2032. IM-1021 is an antibody-d...

2024-06-27 11:27:19 ET Summary Immunome, Inc. stock surged over 400% post-merger and management changes but has since dropped over 60% as initial enthusiasm has waned. The company's new CEO has drawn attention to the company, which has one asset, AL102, in clinical evaluation for ...

2024-06-27 10:45:00 ET It's no secret why Pfizer (NYSE: PFE) stock has been struggling this year. Investors are worried about how well the company will be able to do in light of waning demand for its COVID-19 vaccine and pill. It's also facing patent cliffs for many of its top dru...

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and epidemiological data showing that the JN.1-adapted monovalent COVID-19 vaccine generates an improved ...